Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
24
天
Validation of a QuPath-Based Artificial Intelligence Workflow for Plasma Cell Quantification on CD138 Immunohistochemistry in an Indian Hematopathology Cohort
作者
Mohammed N. Meera; Ankur Ahuja; Venkatesan Somasundaram; Gurpreet Kaur; Parikshit Sanyal; Uday Yanamandra展开收起
作者单位
Department of Pathology, Armed Forces Medical College, Pune, India; Department of Pathology, Command Hospital (Eastern Command), Kolkata, India; Department of Medical Research, Armed Forces Medical College, Pune, India展开收起
51
天
Association of GLP1-Receptor Agonists With Risk of Hematologic Malignancies in People With Diabetes
作者
Samuel Ramos; Shin Zaw; Allison Carilli; Ishak A. Mansi展开收起
作者单位
Department of Internal Medicine, University of Central Florida, Greater Orlando, FL; University of Central Florida College of Medicine, HCA Florida Healthcare GME, Greater Orlando, FL; Section of Hematology and Oncology, Orlando VA Healthcare System, Orlando, FL; Education Services, Orlando VA Healthcare System, Orlando, FL展开收起
51
天
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
作者
Titouan Cazaubiel; Cyrille Touzeau; Laure Vincent; Karim Belhadj; Lionel Karlin; Salomon Manier; Aurore Perrot; Marie Christiane Vekemans; Perrine Moyer; Philippe Moreau; Mohamad Mohty; Judith Victor; Cyrille Hulin展开收起
作者单位
Department of Hematology, University Hospital of Bordeaux, Pessac, France; Cancer Research Center of Toulouse, INSERM, Toulouse, France; Department of Hematology, University Hospital of Nantes, Nantes, France; Department of Hematology, University Hospital of Montpellier, Montpellier, France; Department of Hematology, Hopital Henri Mondor, Creteil, France; Department of Hematology, University Hospital of Lyon, Hospices Civils de Lyon, Lyon, France; Department of Hematology, University Hospital of Lille, Lille, France; Department of Hematology, University Hospital of Toulouse-Oncopole, Toulouse, France; Department of Hematology, St. Luc Hospital, Brussels, Belgium; Department of Hematology, Sorbonne University, Saint-Antoine Hospital, Paris, France展开收起
19
天
Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model
作者
Jodi Lipof; Brian Bloudek; Avik Ray; Jie Ting; Ken Hasegawa; Cynthia Gong; Troy Williams; Scott Ramsey; Ajai Chari展开收起
作者单位
Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA; Curta Inc., Seattle, WA; Arcellx Inc., Redwood City, CA; Kite, a Gilead Company, Santa Monica, CA展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天